Dr Mollie V. Willliams joins Ethics Talk to discuss her article, coauthored with Dr Olaitan Ajisafe: “How Should Exposure Risk to Tactical Personnel Be Balanced Against Clinical and Ethical Rescue Demand?”
Bjorg Thorsteinsdottir, MD, Annika Beck, and Jon C. Tilburt, MD, MPH
Good clinicians understand why a patient is asking for a test or treatment, and their skillful counseling can often stem the tide of requests for marginally beneficial tests and procedures.
AMA J Ethics. 2015; 17(11):1028-1034. doi:
10.1001/journalofethics.2015.17.11.ecas2-1511.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021; 23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
The high prevalence of violence experienced by Native American women and femme-identifying individuals requires clinicians and staff to better understand social determinants of violence.
AMA J Ethics. 2020; 22(10):E888-892. doi:
10.1001/amajethics.2020.888.